Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy
- PMID: 25130892
- DOI: 10.1016/j.survophthal.2014.02.004
Ophthalmic complications of targeted cancer therapy and recently recognized ophthalmic complications of traditional chemotherapy
Abstract
As our understanding of cancer pathophysiology has increased, so have the number of targeted therapeutic agents available. By targeting specific molecules involved in tumorigenesis, targeted therapeutic agents offer the potential for significant efficacy against tumor cells while minimizing the adverse effects. We highlight the recently recognized ophthalmic complications of targeted cancer therapy, as well as recently recognized complications of traditional chemotherapeutic agents.
Keywords: cancer therapy; ocular adverse effect; targeted therapy.
Copyright © 2014 Elsevier Inc. All rights reserved.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
